BASF Enters €664 million Deal to Acquire Pronova and Strengthen Omega 3 Business
date:Nov 22, 2012
e pre-acceptance commitments for approximately 60% of Pronovas share capital; including the 50.0% stake held by majority shareholders Herkules Private Equity Fund (held through its funds Herkules Private Equity (Jersey-I) L.P. and Herkules Private Equity (Jersey-II) L.P.), an approximately 9.1% stake indirectly controlled by investment firms Kistefos AS and Kistefos Investment AS and 0.3% held by members of the Board of Directors and management of Pronova.

The offer corresponds to a premium o
2/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/07 14:50